Can a new pill tame high cholesterol? a phase 1 trial puts SAL0167 to the test

NCT ID NCT07722299

Not yet recruiting Disease control Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This early-stage trial is testing an experimental drug called SAL0167 in healthy adults to see if it is safe and how the body processes it. The goal is to gather initial data that could support future studies for treating high cholesterol. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure how the drug behaves in the body.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an experimental drug called SAL0167
What this could lead to: If safe and effective, SAL0167 could become a new treatment option for managing high cholesterol.
What could go wrong: This is an early phase 1 trial in healthy volunteers, so it is not yet known if the drug works or is safe long-term. Side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERLIPIDEMIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.